Maintaining low HIV seroprevalence in populations of injecting drug users

Don C. Des Jarlais, Holly Hagan, Samuel R. Friedman, Patricia Friedmann, David Goldberg, Martin Frischer, Steven Green, Kerstin Tunving, Bengt Ljungberg, Alex Wodak, Michael Ross, David Purchase, Margaret E. Millson, Ted Myers

Research output: Contribution to journalArticle

Abstract

Objectives. - To describe prevention activities and risk behavior in cities where human immunodeficiency virus (HIV) was introduced into the local population of injecting drug users (IDUs), but where seroprevalence has nevertheless remained low (<5%) during at least 5 years. Design and Setting. - A literature search identified five such cities: Glasgow, Scotland; Lund, Sweden; Sydney, New South Wales, Australia; Tacoma, Wash; and Toronto, Ontario. Case histories were prepared for each city, including data on prevention activities and current levels of risk behavior among IDUs. Participants. - Injecting drug users recruited from both drug treatment and nontreatment settings in each city. Interventions. - A variety of HIV prevention activities for IDUs had been implemented in each of the five cities. Results. - There were three common prevention components present in all five cities: (1) implementation of prevention activities when HIV seroprevalence was still low, (2) provision of sterile injection equipment, and (3) community outreach to IDUs. Moderate levels of risk behavior continued with one third or more of the IDUs reporting recent unsafe injections. Conclusions. - In low-seroprevalence areas, it appears possible to severely limit transmission of HIV among populations of IDUs, despite continuing risk behavior among a substantial proportion of the population. Pending further studies, the common prevention components (beginning early, community outreach, and access to sterile injection equipment) should be implemented wherever populations of IDUs are at risk for rapid spread of HIV.

Original languageEnglish (US)
Pages (from-to)1226-1231
Number of pages6
JournalJournal of the American Medical Association
Volume274
Issue number15
DOIs
StatePublished - Oct 18 1995

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Maintaining low HIV seroprevalence in populations of injecting drug users'. Together they form a unique fingerprint.

  • Cite this

    Des Jarlais, D. C., Hagan, H., Friedman, S. R., Friedmann, P., Goldberg, D., Frischer, M., Green, S., Tunving, K., Ljungberg, B., Wodak, A., Ross, M., Purchase, D., Millson, M. E., & Myers, T. (1995). Maintaining low HIV seroprevalence in populations of injecting drug users. Journal of the American Medical Association, 274(15), 1226-1231. https://doi.org/10.1001/jama.274.15.1226